Product Information
TALICIA DR 10-250-12.5 MG CAP is a brand product labeled by RedHill Biopharma Ltd, priced at $4.8834 per EA under NDC 57841115002. Its NADAC has been published 276 times since Mar 17, 2021.
Strength
250; 10; 12.5 mg/1; mg/1; mg/1
Manufacturer
RedHill Biopharma LtdNDC
57841115002
Classification
Brand
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTINApproval Type
New Drug (NDA)
FDA Application
NDA213004On Market Since
3/9/2020
Pharmacological Classes
Price Statistics
The NADAC for TALICIA DR 10-250-12.5 MG CAP has been published 276 times since Mar 17, 2021, and over the history we have for it it has risen 29.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.8834 per EA |
|---|---|
| All-time high | $4.8834 (Jun 24, 2026) |
| All-time low | $3.7817 (Mar 17, 2021) |
| 52-week high | $4.8834 |
| 52-week low | $4.7584 |
| Median price | $4.3661 |
| Average price | $4.3836 |
| Largest weekly change | +8.0% (Jan 4, 2023) |
| Weeks tracked | 276 |
| Tracking since | Mar 17, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the omeprazole magnesium, amoxicillin and rifabutin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TALICIA DR 10-250-12.5 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for TALICIA DR 10-250-12.5 MG CAP, manufactured by RedHill Biopharma Ltd, is $4.8834 per EA (NDC 57841115002), effective Jun 24, 2026.
How has the price of TALICIA DR 10-250-12.5 MG CAP changed over time?
Over the history we have for it, the NADAC for TALICIA DR 10-250-12.5 MG CAP has risen 29.1%. It has been tracked across 276 weekly CMS publications since Mar 17, 2021.
What are the highest and lowest recorded NADAC prices for TALICIA DR 10-250-12.5 MG CAP?
Since Mar 17, 2021, the NADAC for TALICIA DR 10-250-12.5 MG CAP has ranged from a low of $3.7817 (Mar 17, 2021) to a high of $4.8834 (Jun 24, 2026), with a median of $4.3661 per EA.
Are there cheaper alternatives to TALICIA DR 10-250-12.5 MG CAP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TALICIA DR 10-250-12.5 MG CAP, so no direct lower-cost alternative is listed.
Who manufactures TALICIA DR 10-250-12.5 MG CAP?
TALICIA DR 10-250-12.5 MG CAP (NDC 57841115002) is labeled by RedHill Biopharma Ltd, and CMS classifies it as a brand product.
Related Drugs
Same classification